Olink Holding AB (publ) Overview
Pro stress-test →Olink Holding AB is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. The company utilizes proximity extension assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation.
Strategic Profile
Pro stress-test →Thermo Fisher Scientific completed its acquisition of Olink Holding in July 2024 in a transaction that values Olink at approximately $3.1 billion. The acquisition gives Thermo Fisher access to Olink's proprietary Proximity Extension Assay (PEA) technology, which offers high-throughput protein analysis with a library of more than 5300 validated protein biomarker targets.
Competitive Landscape
Pro stress-test →Olink competes with other proteomics and biomarker discovery platforms including Molecular Devices, Abzena, and Creative Proteomics. The company's PEA technology and extensive validated biomarker library differentiate it in the high-growth precision medicine space.
Industry Context
Olink Holding AB (publ) operates in Life Sciences / Proteomics.
Key facts
Founded: 2004 · Headquarters: Uppsala, Sweden · Employees: 707